Quest Diagnostics Incorporated (DGX) Q4 2016 Earnings Results

Quest Diagnostics Beats on EPS, Stock Up 1.1%

Quest Diagnostics reported a solid EPS performance, which led to a positive stock reaction, rising by 1.1%. The company did not disclose revenue figures or future guidance, leaving some uncertainty for investors. The slight EPS beat suggests the company is managing costs effectively, but the lack of detailed revenue information may raise questions about overall growth prospects.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.31	N/A	+2.83%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting operational improvements. However, they did not provide specific guidance for the upcoming quarters.

We are pleased with our EPS performance this quarter.

Our focus remains on improving operational efficiency.

Quest Diagnostics Beats on EPS, Stock Up 1.1%

Key numbers

Management commentary

Quest Diagnostics Incorporated

More earnings this week

Quest Diagnostics Beats on EPS, Stock Up 1.1%

Key numbers

Management commentary